Table 38 (Abstract P138). Demographics clinical and laboratory characteristics of 225 SLE patients included in analysis
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
| Â | aSLE 139(62%) | cSLE 86 (38%) | P Value |
|---|---|---|---|
Cutanous | 17 (12.2%) | 0 (0.0%) | 0.004 |
Arthritis | 74 (53.2%) | 58 (67.4%) | 0.050 |
Renal | 27 (19.4%) | 42 (48.8%) | P < 0.0005 |
Hematologic | 62 (44.6%) | 19 (22.1%) | 0.001 |
Neurologic | 12 (8.6%) | 15 (17.4%) | 0.078 |
Pulmonary | 4 (2.9%) | 11 (12.8%) | 0.009 |
SLEDAI at disease onset (Mean ± SD) | 8.47 | 13.27 | P < 0.05 |
SLEDAI over disease course (Mean ± SD) | 11.77 | 16.34 | P < 0.05 |